DAPAGLIFLOZIN VERSUS A DIPEPTIDYL PEPTIDASE 4 INHIBITOR (DPP4) BOTH ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): IMPACT ON HEALTH, QUALITY OF LIFE AND COSTS IN THE TURKISH CLINICAL SETTING


Creative Commons License

Malhan S., Guler S., Yetkin İ., Ignacio T. J., Verheggen B., Charokopou M.

VALUE IN HEALTH, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) identifier